| |
| |
|
| Insider
Information: |
Witz Pascale |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
46,947 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,019,325 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
46,947 |
|
|
| Total
Value |
$1,019,325 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Perkinelmer Inc |
PKI |
|
2023-05-15 |
9,098 |
2017-11-15 |
0 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
Director |
2019-05-07 |
37,849 |
2017-12-04 |
0 |
Premium* |
|
|
Tesaro, Inc. |
TSRO |
Director |
2019-01-22 |
0 |
2018-06-01 |
0 |
Premium* |
|
|
Horizon Pharma, Inc. |
HZNP |
Director |
2023-10-06 |
0 |
2023-10-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2023-10-06 |
4 |
D |
$116.50 |
$2,362,504 |
I/I |
(20,279) |
0 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2023-10-06 |
4 |
D |
$116.50 |
$2,990,788 |
D/D |
(25,672) |
0 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
|
– • – |
2023-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,738 |
9,098 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2023-04-28 |
4 |
D |
$111.16 |
$208,870 |
D/D |
(1,879) |
16,323 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2023-04-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,913 |
18,202 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2022-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,354 |
7,360 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2022-04-29 |
4 |
D |
$98.56 |
$163,412 |
I/I |
(1,658) |
43,917 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2022-04-29 |
4 |
OE |
$0.00 |
$0 |
I/I |
4,223 |
45,575 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,313 |
6,006 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2021-04-30 |
4 |
D |
$94.62 |
$412,259 |
I/I |
(4,357) |
41,352 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2021-04-30 |
4 |
OE |
$0.00 |
$0 |
I/I |
11,098 |
45,709 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2020-08-02 |
4 |
D |
$61.19 |
$197,093 |
I/I |
(3,221) |
34,611 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2020-08-02 |
4 |
OE |
$0.00 |
$0 |
I/I |
8,204 |
37,832 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2020-05-08 |
4 |
A |
$0.00 |
$22,497 |
D/D |
2,247 |
4,693 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2020-05-02 |
4 |
D |
$35.62 |
$215,180 |
I/I |
(6,041) |
29,628 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2020-05-02 |
4 |
OE |
$0.00 |
$0 |
I/I |
15,390 |
35,669 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2019-11-21 |
4 |
S |
$90.67 |
$94,569 |
D/D |
(1,043) |
2,446 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2019-08-02 |
4 |
D |
$24.64 |
$79,341 |
I/I |
(3,220) |
20,279 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2019-08-02 |
4 |
OE |
$0.00 |
$0 |
I/I |
8,203 |
23,499 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • – |
2019-05-07 |
4/A |
A |
$1.08 |
$32,000 |
D/D |
29,630 |
37,849 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • – |
2019-05-07 |
4 |
B |
$1.08 |
$32,000 |
D/D |
29,630 |
37,849 |
2.39 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2019-05-03 |
4 |
D |
$26.54 |
$159,612 |
I/I |
(6,014) |
15,296 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2019-05-03 |
4 |
OE |
$0.00 |
$0 |
I/I |
15,320 |
21,310 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2019-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,828 |
3,489 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2019-01-22 |
4 |
D |
$75.00 |
$95,925 |
D/D |
(1,279) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
